These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. Johnson DA J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743 [TBL] [Abstract][Full Text] [Related]
26. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia. Correll CU J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508 [TBL] [Abstract][Full Text] [Related]
27. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study]. Schmidt LG; Siemetzki H Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770 [No Abstract] [Full Text] [Related]
28. Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapy. Brown CS; Wittkowsky AK; Bryant SG Pharmacotherapy; 1986; 6(4):193-5. PubMed ID: 2877444 [TBL] [Abstract][Full Text] [Related]
29. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Casey DE Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821 [No Abstract] [Full Text] [Related]
30. [From neuroleptics toward antipsychotics: practice of changing the treatment, choice of the time and disputes, clinical aspects]. Plas J Encephale; 2003 Sep; 29(Pt 2):S40-2. PubMed ID: 14710536 [No Abstract] [Full Text] [Related]
32. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia. Remington GJ; Voineskos G; Pollock B; Reed K; Coulter K Am J Psychiatry; 1990 Sep; 147(9):1231-3. PubMed ID: 1974747 [TBL] [Abstract][Full Text] [Related]
33. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Lewine RR Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328 [TBL] [Abstract][Full Text] [Related]